Search

The first large study of its kind has found that having a healthy microbiota before starting the process of a bone marrow transplant using a patient’s own cells (autologous) leads to fewer complications after the procedure.

… Thursday, March 18, 2021 A patient’s health after a stem cell or bone marrow transplant (BMT) can depend on the bacteria in their gut. The trillions of microorganisms living there are also known as the microbiota. They can be damaged or wiped out by cancer treatments, leaving patients with severe intestinal

In a study published in the New England Journal of Medicine (NEJM), an MSK team report that they have found what enables cancer cells to become resistant to the experimental drug pirtobrutinib.

… Thursday, February 24, 2022 Since the first targeted therapies for blood cancer were developed more than 20 years ago, doctors and scientists have observed that many patients who respond well to these drugs initially end up developing resistance to them over time. There is an assumption among scientists

Children, teens, and young adults with leukemia that have stopped responding to chemotherapy are the first eligible to receive the new treatment.

… Wednesday, August 30, 2017 Summary A novel form of immunotherapy called CAR T is now an FDA-approved option for people with acute lymphoblastic leukemia (ALL) that has stopped responding to chemotherapy. Our scientists played several key roles in CAR T cell therapy development. In what is being hailed

Thousands of oncology experts from around the world will tune in May 29-31 for the American Society of Clinical Oncology’s (ASCO) Virtual Scientific Program. MSK physicians and scientists are involved in notable research to be presented at the meeting.

… Wednesday, May 27, 2020 Thousands of oncology experts from around the world will tune in May 29-31 for the American Society of Clinical Oncology’s (ASCO) Virtual Scientific Program . The online meeting will provide an engaging lineup of scheduled and on-demand scientific content including a plenary session

GSK's Third Biennial Retreat, April 25-26, will feature clinician-scientist Todd R. Golub in Skytop, Pennsylvania.

… Tuesday, April 22, 2014 The Gerstner Sloan Kettering Graduate School of Biomedical Sciences’ (GSK) Third Biennial Retreat will take place from April 25–26 at Skytop Lodge in Skytop, Pennsylvania. The retreat will feature clinician-scientist Todd R. Golub as the keynote speaker. A founding director and

… Friday, March 20, 2026 Semanti Mukherjee Awarded Chairman’s Prize Third-year student Semanti Mukherjee was awarded the Chairman’s Prize for her first-author paper In vitro mammalian cytotoxicological study of PAMAM dendrimers -towards quantitative structure activity relationships, published March 2009

Learn how a heralded clinical trial that made rectal cancer disappear for every participant is being expanded at Memorial Sloan Kettering Cancer Center. The trial uses only immunotherapy that targets a rare mutation — without the need for surgery, chemotherapy, or radiation.

… Wednesday, August 16, 2023 “I’d always dreamed of having a huge family.” For Kelly Spill, learning she had rectal cancer didn’t only mean facing a potentially life-threatening disease. The diagnosis also threatened many of the things she held dearest in life. Kelly was diagnosed at 28, just months after

A team at MSK has discovered a previously unknown type of resistance to a new leukemia drug.

… Wednesday, June 27, 2018 Summary Drug resistance is when a tumor stops responding to a targeted therapy. It is a serious problem in cancer treatment. Now, a multidisciplinary team has discovered a previously unknown mechanism of resistance to a new leukemia drug. Last summer, the US Food and Drug Administration

There is very little evidence that drinking hot beverages increases esophageal cancer risk.

… Thursday, August 4, 2022 Note: This story was originally published in 2019 and has been updated. It seems that almost every dietary habit has at some point been linked to an increased risk of cancer. In recent years, the idea has emerged that drinking very hot beverages like coffee and tea could contribute

New MSK research shows how high-risk neuroblastoma evolves to be so deadly; finds continued safety and efficacy for sotorasib in patients with KRAS G12C-mutated advanced non-small cell lung cancer; and demonstrates promise in eradicating tumors by delivering a viral-based immunotherapeutic to melanoma and breast cancer in mouse models.

… Thursday, May 18, 2023 New research from  Memorial Sloan Kettering Cancer Center (MSK)  shows how high-risk neuroblastoma evolves to be so deadly; finds continued safety and efficacy for sotorasib in patients with KRAS G12C-mutated advanced non-small cell lung cancer; and demonstrates promise in eradicating